Simplex Trading, LLC Celularity Inc Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.56 - $1.15 $1,248 - $2,563	-2,229 Reduced 69.57%	975 $0
Q4 2022 Feb 02, 2023	BUY	$1.08 - $2.35 $3,460 - $7,529	3,204 New	3,204 $4,000
Q2 2022 Aug 03, 2022	BUY	$2.81 - $12.91 $106,802 - $490,683	38,008 Added 76016.0%	38,058 $129,000
Q1 2022 May 02, 2022	SELL	$3.81 - $9.79 $20,871 - $53,629	-5,478 Reduced 99.1%	50 $0
Q4 2021 Feb 23, 2022	BUY	$4.64 - $7.46 $25,649 - $41,238	5,528 New	5,528 $28,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.